戴纳基(DYN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

DYN 戴纳基

休市中 12-12 16:00:00 EST

19.27

-0.15

-0.77%

盘后19.27

+0.000.00%

19:36 EST

最高19.96	最低19.20	成交量445.41万
今开19.51	昨收19.42	日振幅3.91%
总市值31.18亿	流通市值29.29亿	总股本1.62亿
成交额8,641万	换手率2.93%	流通股本1.52亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"DYN","market":"US","secType":"STK","nameCN":"戴纳基","latestPrice":19.27,"timestamp":1765573200000,"preClose":19.42,"halted":0,"volume":4454140,"hourTrading":{"tag":"盘后","latestPrice":19.27,"preClose":19.27,"latestTime":"19:36 EST","volume":744650,"amount":14349018.8765,"timestamp":1765586181256},"delay":0,"floatShares":152000000,"shares":161805165,"eps":-3.62238,"marketStatus":"休市中","change":-0.15,"latestTime":"12-12 16:00:00 EST","open":19.51,"high":19.9599,"low":19.2,"amount":86408191.37522,"amplitude":0.03913,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.62238,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765789200000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1600315200000,"exchange":"NASDAQ","adjPreClose":19.42,"preHourTrading":{"tag":"盘前","latestPrice":19.2217,"preClose":19.42,"latestTime":"09:24 EST","volume":1892,"amount":36387.674312,"timestamp":1765549450990},"postHourTrading":{"tag":"盘后","latestPrice":19.27,"preClose":19.27,"latestTime":"19:36 EST","volume":744650,"amount":14349018.8765,"timestamp":1765586181256},"volumeRatio":0.7337549310007134,"impliedVol":0.7212,"impliedVolPercentile":0.42},"requestUrl":"/m/hq/s/DYN/tweets","defaultTab":"tweets","newsList":[{"id":"1127475435","title":"戴纳基股价在盘前上涨3.6%，因公司公布肌肉疾病治疗药物的早期至中期临床试验数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1127475435","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1127475435?lang=zh_cn&edition=full","pubTime":"2025-12-08 19:50","pubTimestamp":1765194601,"startTime":"0","endTime":"0","summary":"戴纳基股价在盘前上涨3.6%，因公司公布肌肉疾病治疗药物的早期至中期临床试验数据","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DYN","BK4139","BK4588","BK4585","BK4505"],"gpt_icon":0},{"id":"1141062647","title":"戴纳基公布Z-Rostudirsen在杜氏肌营养不良症（DMD）的一期/二期Deliver试验中取得积极的顶线结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1141062647","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141062647?lang=zh_cn&edition=full","pubTime":"2025-12-08 19:33","pubTimestamp":1765193595,"startTime":"0","endTime":"0","summary":"戴纳基公布Z-Rostudirsen在杜氏肌营养不良症（DMD）的一期/二期Deliver试验中取得积极的顶线结果","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DYN","BK4588","BK4505","BK4585"],"gpt_icon":0},{"id":"2584967027","title":"戴纳基盘中异动 下午盘大幅上涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584967027","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584967027?lang=zh_cn&edition=full","pubTime":"2025-11-19 02:25","pubTimestamp":1763490313,"startTime":"0","endTime":"0","summary":"北京时间2025年11月19日02时25分，戴纳基股票出现波动，股价急速上涨5.04%。截至发稿，该股报21.26美元/股，成交量118.282万股，换手率0.83%，振幅8.37%。戴纳基股票所在的生物技术行业中，整体涨幅为0.40%。FORCE 平台的治疗药物包括一个合理设计以针对疾病遗传基础的药物载体、一个连接子和一个抗原结合片段，抗原结合片段通过连接子连接到药物载体上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511190225149771b020&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511190225149771b020&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4505","DYN","BK4588","BK4139"],"gpt_icon":0},{"id":"2581886929","title":"戴纳基盘中异动 快速下挫5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581886929","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581886929?lang=zh_cn&edition=full","pubTime":"2025-11-06 22:35","pubTimestamp":1762439735,"startTime":"0","endTime":"0","summary":"北京时间2025年11月06日22时35分，戴纳基股票出现波动，股价快速跳水5.02%。截至发稿，该股报19.85美元/股，成交量6.7481万股，换手率0.05%，振幅6.32%。机构评级方面，在所有16家参与评级的机构中，81%的券商给予买入建议，19%的券商给予持有建议，无券商给予卖出建议。戴纳基股票所在的生物技术行业中，整体涨幅为0.10%。戴纳基公司简介：Dyne Therapeutics Inc 是一家处于临床阶段的神经肌肉疾病公司，专注于发现和推进针对遗传性神经肌肉疾病患者的变革性治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106223536a6e635c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106223536a6e635c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4585","DYN","BK4505","BK4139"],"gpt_icon":0},{"id":"2574101977","title":"戴纳基盘中异动 急速跳水5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574101977","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574101977?lang=zh_cn&edition=full","pubTime":"2025-10-10 23:01","pubTimestamp":1760108483,"startTime":"0","endTime":"0","summary":"北京时间2025年10月10日23时01分，戴纳基股票出现异动，股价快速跳水5.01%。截至发稿，该股报13.95美元/股，成交量43.1644万股，换手率0.30%，振幅2.17%。机构评级方面，在所有16家参与评级的机构中，81%的券商给予买入建议，19%的券商给予持有建议，无券商给予卖出建议。戴纳基股票所在的生物技术行业中，整体跌幅为0.63%。消息层面，截至23时01分，《摩根士丹利维持戴纳基买入评级，维持目标价48美元》资讯为影响戴纳基的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101023012394c20a66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101023012394c20a66&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4588","BK4585","DYN","BK4505"],"gpt_icon":0},{"id":"1147655715","title":"戴纳基公布额外一年临床数据，显示治疗肌强直性营养不良1型药物Zeleciment Basivarsen在1/2期ACHIEVE试验中展现功能性改善","url":"https://stock-news.laohu8.com/highlight/detail?id=1147655715","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1147655715?lang=zh_cn&edition=full","pubTime":"2025-10-07 06:02","pubTimestamp":1759788136,"startTime":"0","endTime":"0","summary":"戴纳基近日公布了其候选药物Zeleciment Basivarsen (Dyne-101)在治疗肌强直性营养不良1型(DM1)方面的额外一年临床数据。该数据来自1/2期ACHIEVE试验，结果显示患者出现功能性改善。\n这项临床试验为期一年的追踪数据进一步证实了Zeleciment Basivarsen在治疗这种罕见遗传性疾病方面的潜在疗效。肌强直性营养不良1型是一种影响肌肉功能的遗传性疾病，目前缺乏有效的治疗选择。\nACHIEVE试验的最新数据为该药物的进一步开发提供了重要支持，也为DM1患者群体带来了新的治疗希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DYN","BK4139","BK4588","BK4585","BK4505"],"gpt_icon":0},{"id":"1123331202","title":"戴纳基Dyne Therapeutics旗下Dyne-251获得日本孤儿药认定，用于治疗杜氏肌营养不良症","url":"https://stock-news.laohu8.com/highlight/detail?id=1123331202","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123331202?lang=zh_cn&edition=full","pubTime":"2025-09-29 20:37","pubTimestamp":1759149445,"startTime":"0","endTime":"0","summary":"戴纳基Dyne Therapeutics宣布，其药物候选产品Dyne-251已获得日本监管部门的孤儿药认定，该药物用于治疗杜氏肌营养不良症。这一认定为公司在日本市场推进该治疗方案的开发提供了重要的监管支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DYN","BK4588","BK4139","BK4505","BK4585"],"gpt_icon":0},{"id":"2568118216","title":"戴纳基盘中异动 急速下挫5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568118216","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568118216?lang=zh_cn&edition=full","pubTime":"2025-09-20 02:48","pubTimestamp":1758307682,"startTime":"0","endTime":"0","summary":"北京时间2025年09月20日02时48分，戴纳基股票出现波动，股价大幅下跌5.03%。截至发稿，该股报13.22美元/股，成交量88.1149万股，换手率0.62%，振幅5.17%。机构评级方面，在所有17家参与评级的机构中，88%的券商给予买入建议，12%的券商给予持有建议，无券商给予卖出建议。戴纳基股票所在的生物技术行业中，整体跌幅为0.56%。戴纳基公司简介：Dyne Therapeutics Inc 是一家处于临床阶段的神经肌肉疾病公司，专注于发现和推进针对遗传性神经肌肉疾病患者的变革性治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250920024802a4378dbc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250920024802a4378dbc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DYN","BK4588","BK4139","BK4505","BK4585"],"gpt_icon":0},{"id":"1104009196","title":"戴纳基：Raymond James将评级上调至\"强烈买入\"，目标价上调至35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1104009196","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104009196?lang=zh_cn&edition=full","pubTime":"2025-08-25 19:15","pubTimestamp":1756120516,"startTime":"0","endTime":"0","summary":"Raymond James将戴纳基(Dyne Therapeutics, Inc.)的投资评级从\"跑赢大盘\"上调至\"强烈买入\"，同时将目标价从31美元上调至35美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4505","BK4588","BK4585","DYN"],"gpt_icon":0},{"id":"2561328711","title":"戴纳基盘中异动 早盘股价大涨5.07%报12.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2561328711","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561328711?lang=zh_cn&edition=full","pubTime":"2025-08-22 22:14","pubTimestamp":1755872085,"startTime":"0","endTime":"0","summary":"北京时间2025年08月22日22时14分，戴纳基股票出现波动，股价大幅上涨5.07%。截至发稿，该股报12.84美元/股，成交量26.872万股，换手率0.19%，振幅4.87%。机构评级方面，在所有17家参与评级的机构中，88%的券商给予买入建议，12%的券商给予持有建议，无券商给予卖出建议。戴纳基股票所在的生物技术行业中，整体涨幅为0.31%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250822221445975926bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250822221445975926bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4505","DYN","BK4139","BK4585"],"gpt_icon":0},{"id":"2557032293","title":"戴纳基盘中异动 早盘股价大跌5.06%报9.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557032293","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557032293?lang=zh_cn&edition=full","pubTime":"2025-08-06 22:46","pubTimestamp":1754491569,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日22时46分，戴纳基股票出现异动，股价大幅下跌5.06%。截至发稿，该股报9.94美元/股，成交量66.7474万股，换手率0.47%，振幅4.08%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.11亿美元，每股收益-0.97美元，毛利-500000.00美元，市盈率-2.56倍。机构评级方面，在所有17家参与评级的机构中，88%的券商给予买入建议，12%的券商给予持有建议，无券商给予卖出建议。戴纳基股票所在的生物技术行业中，整体跌幅为0.13%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806224610a478f72d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806224610a478f72d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","BK4585","BK4588","DYN"],"gpt_icon":0},{"id":"2556817230","title":"戴纳基2025财年第二财季实现净利润-1.11亿美元，同比减少70.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556817230","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556817230?lang=zh_cn&edition=full","pubTime":"2025-08-02 00:00","pubTimestamp":1754064043,"startTime":"0","endTime":"0","summary":"8月2日，戴纳基公布财报，公告显示公司2025财年第二财季净利润为-1.11亿美元，同比减少70.51%；其中营业收入为0.00美元，每股基本收益为-0.97美元。从资产负债表来看，戴纳基总负债1.58亿美元，其中短期债务5.00百万美元，资产负债比为4.62，流动比率为0.17。机构评级：截至2025年8月2日，当前有17家机构对戴纳基目标价做出预测，其中目标均价为36.32美元，其中最低目标价为9.00美元，最高目标价为50.00美元。其研发管线包括 DYNE-101、DYNE-251、DYNE-302 和 DYNE-401。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802000101a6ce1eb6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802000101a6ce1eb6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DYN"],"gpt_icon":0},{"id":"2555047211","title":"戴纳基盘中异动 早盘大幅上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555047211","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555047211?lang=zh_cn&edition=full","pubTime":"2025-07-30 21:44","pubTimestamp":1753883086,"startTime":"0","endTime":"0","summary":"北京时间2025年07月30日21时44分，戴纳基股票出现异动，股价快速上涨5.00%。截至发稿，该股报9.66美元/股，成交量17.9538万股，换手率0.13%，振幅4.02%。机构评级方面，在所有17家参与评级的机构中，88%的券商给予买入建议，12%的券商给予持有建议，无券商给予卖出建议。戴纳基股票所在的生物技术行业中，整体涨幅为0.37%。戴纳基公司简介：Dyne Therapeutics Inc 是一家处于临床阶段的神经肌肉疾病公司，专注于发现和推进针对遗传性神经肌肉疾病患者的变革性治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507302144469727e390&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507302144469727e390&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4585","BK4588","BK4139","DYN"],"gpt_icon":0},{"id":"2554777340","title":"戴纳基盘中异动 股价大跌5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554777340","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554777340?lang=zh_cn&edition=full","pubTime":"2025-07-28 21:53","pubTimestamp":1753710796,"startTime":"0","endTime":"0","summary":"北京时间2025年07月28日21时53分，戴纳基股票出现异动，股价急速下挫5.23%。截至发稿，该股报9.43美元/股，成交量16.9733万股，换手率0.12%，振幅4.72%。机构评级方面，在所有17家参与评级的机构中，88%的券商给予买入建议，12%的券商给予持有建议，无券商给予卖出建议。戴纳基股票所在的生物技术行业中，整体涨幅为0.05%。戴纳基公司简介：Dyne Therapeutics Inc 是一家处于临床阶段的神经肌肉疾病公司，专注于发现和推进针对遗传性神经肌肉疾病患者的变革性治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728215316a467e1d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728215316a467e1d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DYN","BK4139","BK4505","BK4588","BK4585"],"gpt_icon":0},{"id":"2552357487","title":"戴纳基盘中异动 早盘股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552357487","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552357487?lang=zh_cn&edition=full","pubTime":"2025-07-17 22:08","pubTimestamp":1752761332,"startTime":"0","endTime":"0","summary":"北京时间2025年07月17日22时08分，戴纳基股票出现异动，股价大幅拉升5.04%。截至发稿，该股报9.80美元/股，成交量35.703万股，换手率0.25%，振幅3.76%。机构评级方面，在所有17家参与评级的机构中，88%的券商给予买入建议，12%的券商给予持有建议，无券商给予卖出建议。戴纳基股票所在的生物技术行业中，整体涨幅为0.39%。戴纳基公司简介：Dyne Therapeutics Inc 是一家处于临床阶段的神经肌肉疾病公司，专注于发现和推进针对遗传性神经肌肉疾病患者的变革性治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507172208529546420d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507172208529546420d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DYN","BK4588","BK4139","BK4505","BK4585"],"gpt_icon":0},{"id":"2551919313","title":"戴纳基盘中异动 早盘股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551919313","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551919313?lang=zh_cn&edition=full","pubTime":"2025-07-15 22:37","pubTimestamp":1752590235,"startTime":"0","endTime":"0","summary":"北京时间2025年07月15日22时37分，戴纳基股票出现波动，股价快速跳水5.05%。截至发稿，该股报8.46美元/股，成交量41.9552万股，换手率0.30%，振幅7.18%。机构评级方面，在所有17家参与评级的机构中，88%的券商给予买入建议，12%的券商给予持有建议，无券商给予卖出建议。戴纳基股票所在的生物技术行业中，整体跌幅为0.16%。戴纳基公司简介：Dyne Therapeutics Inc 是一家处于临床阶段的神经肌肉疾病公司，专注于发现和推进针对遗传性神经肌肉疾病患者的变革性治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715223715a44ca8e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715223715a44ca8e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4585","BK4505","BK4139","DYN"],"gpt_icon":0},{"id":"2551182939","title":"戴纳基盘中异动 早盘股价大涨5.09%报9.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551182939","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551182939?lang=zh_cn&edition=full","pubTime":"2025-07-14 22:22","pubTimestamp":1752502969,"startTime":"0","endTime":"0","summary":"北京时间2025年07月14日22时22分，戴纳基股票出现波动，股价快速拉升5.09%。截至发稿，该股报9.08美元/股，成交量87.0423万股，换手率0.61%，振幅4.98%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.15亿美元，每股收益-1.05美元，毛利-502000.00美元，市盈率-2.51倍。机构评级方面，在所有17家参与评级的机构中，88%的券商给予买入建议，12%的券商给予持有建议，无券商给予卖出建议。戴纳基股票所在的生物技术行业中，整体涨幅为1.06%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714222249a44a341f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714222249a44a341f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DYN","BK4139","BK4588","BK4585","BK4505"],"gpt_icon":0},{"id":"2550521692","title":"戴纳基盘中异动 快速上涨5.01%报8.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550521692","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550521692?lang=zh_cn&edition=full","pubTime":"2025-07-08 23:42","pubTimestamp":1751989366,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日23时42分，戴纳基股票出现波动，股价急速拉升5.01%。截至发稿，该股报8.59美元/股，成交量126.573万股，换手率0.89%，振幅3.91%。机构评级方面，在所有17家参与评级的机构中，88%的券商给予买入建议，12%的券商给予持有建议，无券商给予卖出建议。戴纳基股票所在的生物技术行业中，整体涨幅为1.18%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708234247953b03f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708234247953b03f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4505","BK4588","DYN","BK4139"],"gpt_icon":0},{"id":"2549553944","title":"戴纳基盘中异动 早盘股价大跌5.02%报8.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549553944","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549553944?lang=zh_cn&edition=full","pubTime":"2025-07-07 21:49","pubTimestamp":1751896140,"startTime":"0","endTime":"0","summary":"北京时间2025年07月07日21时49分，戴纳基股票出现异动，股价急速下挫5.02%。截至发稿，该股报8.32美元/股，成交量14.4218万股，换手率0.10%，振幅5.71%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.15亿美元，每股收益-1.05美元，毛利-502000.00美元，市盈率-2.31倍。机构评级方面，在所有17家参与评级的机构中，88%的券商给予买入建议，12%的券商给予持有建议，无券商给予卖出建议。戴纳基股票所在的生物技术行业中，整体跌幅为0.68%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707214901979d1bfe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707214901979d1bfe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4588","BK4505","DYN","BK4585"],"gpt_icon":0},{"id":"2548470816","title":"戴纳基盘中异动 早盘股价大涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548470816","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548470816?lang=zh_cn&edition=full","pubTime":"2025-07-02 22:51","pubTimestamp":1751467897,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日22时51分，戴纳基股票出现异动，股价急速上涨5.07%。截至发稿，该股报9.12美元/股，成交量95.8349万股，换手率0.84%，振幅4.38%。机构评级方面，在所有17家参与评级的机构中，88%的券商给予买入建议，12%的券商给予持有建议，无券商给予卖出建议。戴纳基股票所在的生物技术行业中，整体涨幅为0.69%。戴纳基公司简介：Dyne Therapeutics Inc 是一家处于临床阶段的神经肌肉疾病公司，专注于发现和推进针对遗传性神经肌肉疾病患者的变革性治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702225137a72adc8a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702225137a72adc8a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DYN","BK4139","BK4505","BK4588","BK4585"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.dyne-tx.com","stockEarnings":[{"period":"1week","weight":-0.0498},{"period":"1month","weight":0.0355},{"period":"3month","weight":0.4654},{"period":"6month","weight":0.3373},{"period":"1year","weight":-0.2476},{"period":"ytd","weight":-0.1821}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Dyne Therapeutics, Inc.于2017年12月1日根据特拉华州法律注册成立。该公司正在建立一家领先的肌肉疾病公司，致力于开发针对遗传驱动疾病患者的创新性改变生命的疗法。该公司正在利用其专有的FORCE平台来克服当前肌肉组织输送的局限性，并发展用于肌肉疾病的现代寡核苷酸疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.003365},{"month":2,"riseRate":0.4,"avgChangeRate":0.04136},{"month":3,"riseRate":0.4,"avgChangeRate":-0.063194},{"month":4,"riseRate":0.4,"avgChangeRate":0.002599},{"month":5,"riseRate":0.6,"avgChangeRate":0.021103},{"month":6,"riseRate":0.6,"avgChangeRate":0.059122},{"month":7,"riseRate":0.8,"avgChangeRate":0.143805},{"month":8,"riseRate":0.4,"avgChangeRate":0.05015},{"month":9,"riseRate":0.2,"avgChangeRate":-0.048359},{"month":10,"riseRate":0.333333,"avgChangeRate":0.031774},{"month":11,"riseRate":0.5,"avgChangeRate":0.097108},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.046841}],"exchange":"NASDAQ","name":"戴纳基","nameEN":"Dyne Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"戴纳基(DYN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供戴纳基(DYN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"戴纳基,DYN,戴纳基股票,戴纳基股票老虎,戴纳基股票老虎国际,戴纳基行情,戴纳基股票行情,戴纳基股价,戴纳基股市,戴纳基股票价格,戴纳基股票交易,戴纳基股票购买,戴纳基股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"戴纳基(DYN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供戴纳基(DYN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}